EA201791356A1 - PHOSPHORAMIDATES FOR THE TREATMENT OF HEPATITIS B VIRUS - Google Patents

PHOSPHORAMIDATES FOR THE TREATMENT OF HEPATITIS B VIRUS

Info

Publication number
EA201791356A1
EA201791356A1 EA201791356A EA201791356A EA201791356A1 EA 201791356 A1 EA201791356 A1 EA 201791356A1 EA 201791356 A EA201791356 A EA 201791356A EA 201791356 A EA201791356 A EA 201791356A EA 201791356 A1 EA201791356 A1 EA 201791356A1
Authority
EA
Eurasian Patent Office
Prior art keywords
phosphoramidates
hepatitis
virus
treatment
compounds
Prior art date
Application number
EA201791356A
Other languages
Russian (ru)
Other versions
EA039123B1 (en
Inventor
Абел Де Ла Роса
Джордж Пейнтер
Грегори P. Блуемлинг
Original Assignee
Эмори Юниверсити
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Эмори Юниверсити filed Critical Эмори Юниверсити
Priority claimed from PCT/US2015/064338 external-priority patent/WO2016099982A2/en
Publication of EA201791356A1 publication Critical patent/EA201791356A1/en
Publication of EA039123B1 publication Critical patent/EA039123B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/005—Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/09—Pyrimidine radicals with arabinosyl as the saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Abstract

Раскрыты соединения для лечения инфекционных заболеваний и способы лечения таких заболеваний. Соединения представляют собой производные клевудина.Disclosed are compounds for treating infectious diseases and methods for treating such diseases. Compounds are derivatives of horn.

EA201791356A 2014-12-15 2015-12-07 Phosphoramidates for the treatment of hepatitis b virus EA039123B1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US62/091,686 2014-12-15
US62/094,117 2014-12-19
US201562201974P 2015-08-06 2015-08-06
US62/201,974 2015-08-06
PCT/US2015/064338 WO2016099982A2 (en) 2014-12-15 2015-12-07 Phosphoramidates for the treatment of hepatitis b virus

Publications (2)

Publication Number Publication Date
EA201791356A1 true EA201791356A1 (en) 2017-12-29
EA039123B1 EA039123B1 (en) 2021-12-08

Family

ID=80632885

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201791356A EA039123B1 (en) 2014-12-15 2015-12-07 Phosphoramidates for the treatment of hepatitis b virus

Country Status (1)

Country Link
EA (1) EA039123B1 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3687931A (en) * 1970-03-19 1972-08-29 Syntex Corp Halogenated purine and pyrimidine nucleosides and process therefor
US5587362A (en) * 1994-01-28 1996-12-24 Univ. Of Ga Research Foundation L-nucleosides
US20040229839A1 (en) * 2003-05-14 2004-11-18 Biocryst Pharmaceuticals, Inc. Substituted nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases

Also Published As

Publication number Publication date
EA039123B1 (en) 2021-12-08

Similar Documents

Publication Publication Date Title
PH12017550022A1 (en) Phosphoramidates for the treatment of hepatitis b virus
ZA201900156B (en) Phosphoramidates for the treatment of hepatitis b virus
DK3597646T3 (en) THERAPEUTIC COMPOUNDS SUITABLE FOR THE PROHYPHYLACTIC OR THERAPEUTIC TREATMENT OF AN HIV VIRUS INFECTION
EA201890731A1 (en) Modulators of the cow protein HEPATITIS B
EA201790630A1 (en) METHODS OF OBTAINING RIBOSIDS
EA201691726A1 (en) NEW 6-CONDENSED HETEROARYDYDYDROPYRIMIDIDES FOR THE TREATMENT AND PREVENTION OF HEPATITIS B VIRUS INFECTION
MX2019003525A (en) Hepatitis b core protein allosteric modulators.
MX2018005569A (en) Vaccines against hepatitis b virus.
EA201791515A1 (en) COMPOUNDS OF PYRAZINE FOR THE TREATMENT OF INFECTIOUS DISEASES
EA201791460A1 (en) N4-HYDROXYCYTIDINE AND RELATED DERIVATIVES AND OPTIONS FOR ANTI-VIRUS APPLICATION
EA201792069A1 (en) DERIVATIVES OF AZOKANES AND AZONAS AND METHODS OF TREATING INFECTIONS OF HEPATITIS B
EA201692473A1 (en) METHODS OF OBTAINING SUBSTITUTED NUCLEOTIDE ANALOGS
EA201790700A1 (en) MONO OR DESIGNED INDOLS AS AN INHIBITORS REPLICATION OF DENG VIRUSES
EA201891399A1 (en) BIPIRAZOLE DERIVATIVES, SUITABLE FOR THE TREATMENT OF AUTOIMMUNE DISEASES
EA201692358A1 (en) IZOINDOLIN DERIVATIVES FOR USE IN THE TREATMENT OF VIRAL INFECTION
MA43925A (en) Hepatitis B virus treatment process
EA201892448A1 (en) ALKYN-CONTAINING NUCLEOTIDE AND NUCLEOSIDE THERAPEUTIC COMPOSITIONS AND RELATED APPLICATION METHODS
EA201790776A1 (en) COMBINED COMPOSITIONS OF LONG-TERM ACTIONS AND METHODS OF TREATING HEPATITIS C
EA201790771A1 (en) PHARMACEUTICAL COMPOSITIONS OF LONG-TERM ACTION FOR THE TREATMENT OF HEPATITIS C
IL279078A (en) Combination therapy for treating hepatitis b virus infection
EA201791356A1 (en) PHOSPHORAMIDATES FOR THE TREATMENT OF HEPATITIS B VIRUS
TR201910305T4 (en) Compounds to treat viral infections.
EA201890818A1 (en) COMBINED TREATMENT FOR HCV TREATMENT
EA201992054A1 (en) CYCLIC SULFAMIDE COMPOUNDS AND WAYS OF THEIR APPLICATION
EA201691835A1 (en) ALLASTERIC MODULATORS OF CAPSIDE PROTEIN OF HEPATITIS B